ZNF860 has been associated with early-onset type 2 diabetes mellitus and prostate cancer, and its higher expression is seen as an indicator for gastric cancer (Dmitriev et al., 2015; Yamada et al., 2018; Pan et al., 2019). Here, ZNF860 is linked to prostate cancer.